On February 28, 2023, the company received $1,700,000 in its first tranche. The transaction included participation from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd. and Huons Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34,350 KRW | +0.29% | +1.78% | -10.55% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
67,500 KRW | -2.17% | -2.32% | 427M | ||
34,350 KRW | +0.29% | +1.78% | 296M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.55% | 296M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A243070 Stock
- News Huons Co., Ltd.
- GenEdit Inc. amended terms of the transaction